Quick Overview: Dr Michael J Mack (Baylor Scott & White Heart Hospital, Plano, TX, US) discusses the two-year clinical and echocardiographic ... Martin Leon, MD and Michael Mack, MD provide an overview of the results of CardioSource Editors Chris Cannon and Deepak Bhatt preview late breaking clinical
Acc 13 Partner Trial Three - Detailed Overview & Context
Dr Michael J Mack (Baylor Scott & White Heart Hospital, Plano, TX, US) discusses the two-year clinical and echocardiographic ... Martin Leon, MD and Michael Mack, MD provide an overview of the results of CardioSource Editors Chris Cannon and Deepak Bhatt preview late breaking clinical Treatment of Anemia in Chronic HF with an Erythropoetin Stimulating Agent. Results of RED-HF (Reduction of Events with ... In this short virtual interview, we are joined by Dr Martin B Leon (Columbia University Medical Center, US) to discuss the 5-year ... Late-breaker host Dr Harriette Van Spall (McMaster University, Hamilton, CA) is joined onsite by Michiel Voskuil (UMC Utrecht, ...
Roundtable discussion on Monday's LBCT Highlights from Dr Michael Mack (Baylor Scott & White Heart Hospital, Plano, US) joins us to share the clinical and echocardiographic outcomes ... An interventional cardiologist shares perspective on what the new two-year TAVR findings mean for him and colleagues. Watch the full video on Radcliffe Cardiology here: ... Late-breaker host, Dr Harriette Van Spall (McMaster University, CA) is joined by Dr Neha J Pagidipati (Duke University Medical ... The global coronavirus pandemic restructured the American College of Cardiology Scientific Sessions into a virtual meeting this ...
Amit Khera, MD, MSc, FAHA and Joanna Chikwe, MD, FAHA, chairs of the American Heart Association Committee on Scientific ... um so discussion um so the um conclusions were that among these 314 patients with severe TR this was the first randomized
